693
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Latest pharmacotherapy options for benign prostatic hyperplasia

, , , , , , , , & , MD show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Feng He, Li-bo Man, Gui-zhong Li & Ning Liu. (2016) Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison. Drug Design, Development and Therapy 10, pages 1783-1793.
Read now
Andrea Russo, Paolo Capogrosso, Giovanni La Croce, Eugenio Ventimiglia, Luca Boeri, Alberto Briganti, Rocco Damiano, Francesco Montorsi & Andrea Salonia. (2016) Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opinion on Drug Safety 15:12, pages 1661-1670.
Read now
Mancheng Gong, Wenjing Dong, Guiying Huang, Zhaoyang Gong, Decheng Deng, Shaopeng Qiu & Runqiang Yuan. (2015) Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis. Current Medical Research and Opinion 31:9, pages 1781-1792.
Read now

Articles from other publishers (13)

Abdel Qader Al Bawab, Bashar A. Alkhalidi, Esra'a Albarahmieh, Sami M.A. Qassim, Mohammad A.D. Al‐Saifi, Bashar Al‐Saifi, Jonathan Ling & Walid Al‐Qerem. (2020) Pharmacokinetics and Bioequivalence Estimation of Two Formulations of Alfuzosin Extended‐Release Tablets. Clinical Pharmacology in Drug Development 9:7, pages 780-784.
Crossref
Yuxuan Song, Guangyuan Chen, Peng Huang, Cong Hu & Xiaoqiang Liu. (2020) Effects of Tamsulosin Combined With Solifenacin on Lower Urinary Tract Symptoms: Evidence From a Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials. Frontiers in Pharmacology 11.
Crossref
Gina M. Powley & Gail M. Briolat. 2020. The Nurse Practitioner in Urology. The Nurse Practitioner in Urology 119 131 .
Robert E. Pyke. (2019) Toward a Scientific Nutritional Supplement Combination for Prostatism and Erectile Dysfunction I: From Known Pharmacology to Clinical Testing. Journal of Medicinal Food 22:5, pages 529-537.
Crossref
Jacklyn N. Hellwege, Sarah Stallings, Eric S. Torstenson, Robert Carroll, Kenneth M. Borthwick, Murray H. Brilliant, David Crosslin, Adam Gordon, George Hripcsak, Gail P. Jarvik, James G. Linneman, Parimala Devi, Peggy L. Peissig, Patrick A. M. Sleiman, Hakon Hakonarson, Marylyn D. Ritchie, Shefali Setia Verma, Ning Shang, Josh C. Denny, Dan M. Roden, Digna R. Velez Edwards & Todd L. Edwards. (2019) Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network. Scientific Reports 9:1.
Crossref
Smita Pattanaik, Ravimohan S Mavuduru, Arabind Panda, Joseph L Mathew, Mayank M Agarwal, Eu Chang Hwang, Jennifer A Lyon, Shrawan K Singh & Arup K Mandal. (2018) Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2018:11.
Crossref
Luca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, Walter Cazzaniga, Filippo Pederzoli, Donatella Moretti, Federico Dehò, Emanuele Montanari, Francesco Montorsi & Andrea Salonia. (2017) Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone. Scientific Reports 7:1.
Crossref
XiangYun Liu, Guoyuan Huang, Peijie Chen, Yong Li, JiuLin Xiang, Ting Chen & Ru Wang. (2016) Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia-related outcomes in older adults: study protocol for a randomized controlled trial. Trials 17:1.
Crossref
Renata Oliveira Silva, Andressa Souza de Oliveira, Laís Flávia Nunes Lemes, Luciana de Camargo Nascente, Patrícia Coelho do Nascimento Nogueira, Edilberto R. Silveira, Guilherme D. Brand, Giulio Vistoli, Antonio Cilia, Elena Poggesi, Michela Buccioni, Gabriella Marucci, Maria Laura Bolognesi & Luiz Antonio Soares Romeiro. (2016) Synthesis and structure–activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor. European Journal of Medicinal Chemistry 122, pages 601-610.
Crossref
Fei Zhao, Jing Li, Ying Chen, Yanxin Tian, Chenglin Wu, Yanan Xie, Yu Zhou, Jiang Wang, Xin Xie & Hong Liu. (2016) Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective α 1A -Adrenoceptor Antagonists . Journal of Medicinal Chemistry 59:8, pages 3826-3839.
Crossref
Gail M. Briolat. 2016. The Nurse Practitioner in Urology. The Nurse Practitioner in Urology 117 126 .
Umamaheswar Duvvuri. (2015) ANO1 plays a critical role in prostatic hyperplasia. Proceedings of the National Academy of Sciences 112:31, pages 9506-9507.
Crossref
Gillian M. Keating. (2015) Silodosin: A Review of Its Use in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia. Drugs 75:2, pages 207-217.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.